期刊文献+

糖尿病患者血清肝细胞生长因子水平及临床意义 被引量:1

Level and significance of hepatocyte growth factor in serum of diabetic nephropathy
原文传递
导出
摘要 目的探讨血清肝细胞生长因子(HGF)在2型DM不同肾损害期中的变化、临床意义及糖尿病肾病发生发展中的作用。方法将2型DM患者92例分为不同的组别,其中尿白蛋白正常组30例,尿白蛋白微量组32例,尿白蛋白明显增高组30例;糖耐量异常患者33例,采用ELISA法检测血清HGF水平,同时用化学发光法检测尿微量白蛋白。结果糖耐量异常组和尿白蛋白正常组HGF浓度明显高于对照组(P<0.05);尿白蛋白微量组及尿白蛋白明显增高组HGF浓度明显低于对照组(P<0.05);且尿白蛋白明显增高组又显著低于尿白蛋白微量组(P<0.05)。结论2型DM患者不同肾损害期HGF浓度差别有统计学意义,检测血HGF水平可为糖尿病肾病的诊断和治疗监测提供可靠依据。 Objective To study the changes and chnical significance of serum hepatocyte growth factor (HGF) in different period of kidney damage in type 2 diabetic patients. Methods There 92 type 2 diabetic patients were divided into three groups including the normal albuminuria group (Group A) consisted of 30 cases,a little over normal albuminuria group consisted of 32 patients (Group.B)and a high albuminuria group consisted of 30 case (Group C). Another 33 glucose resistent patients were respectively collected,and serum HGF levels were tested with ELISA,the urine in 24 hours was collected for detection of urinary micro-albumin. Results HGF concentrations in glucose resistence in Group A and Group B were significandy higher than that of control group (P〈0. 05),HGF concentrations in large more than normal albuminuria group is significantly lower than that in micro-albuminuria group(P〈0. 05). Conclusion There is statistical significance of HGF concentrations in different kidney damage stages of type 2 diabetic, and serum levels of HGF can provide a dependable theoretical basis for diagnosis and treatment-monitoring of diabetic nephropathy.
出处 《中国热带医学》 CAS 2009年第7期1192-1193,共2页 China Tropical Medicine
关键词 肝细胞生长因子 尿白蛋白 糖尿病肾病 Hepatocyte growth factor(HGF) Urinary albuminuria Diabetic nephmpathy
  • 相关文献

参考文献6

二级参考文献51

  • 1袁庆新,刘超.肝细胞生长因子和糖尿病肾病[J].国外医学(内科学分册),2006,33(1):21-23. 被引量:11
  • 2Miyazawa K, Tsubouchi H, Naka D, et al. [J].Biochem Biophys Res Commun, 1989, 163: 967-973.
  • 3Zarnegar R, Michalopoulos GK. [J]. J Cell Biol,1995,129 : 1177-1180.
  • 4Michalopulos GK, DeFrances MC.[J]. Science,1997,276 : 60-66.
  • 5Matsumoto K, Nakamura T. [J]. Kidney Int,2001,59 : 2023-2038.
  • 6Liu Y, Rajur K, Tolbert E, et al. [J]. Kidney Int, 2000,58 : 2028 -2043.
  • 7Gareia-Oeana A, Takane KK, Syed MA, et al.[J]. J Biol Chem,2000,275 : 1226-1232.
  • 8Dai CS, Li YJ, Yang JW, et al. [J]. J Biol Chem, 2003,278 : 27080-27087.
  • 9Dai C, Liu Y. [J]. J Am Soc Nephrot,2004, 151(6) :1402-1412.
  • 10Esposito C, Parrilla B, De Mauri A. [J]. Kidney Int,2005,67(6) :2143-2150.

共引文献20

同被引文献36

  • 1安娜,刘惠兰,王英.2型糖尿病肾病大鼠肾小管间质病变及TGF-β1、HGF和CTGF表达的变化及意义[J].首都医科大学学报,2008,29(3):315-320. 被引量:12
  • 2纪志尚,刘秀英.糖尿病患者血清肿瘤坏死因子-α水平与糖尿病肾病的关系[J].实用诊断与治疗杂志,2007,21(3):181-182. 被引量:11
  • 3张慧荣,李兴.肿瘤坏死因子-α在糖尿病肾脏病变中的作用[J].山西医科大学学报,2007,38(7):581-584. 被引量:7
  • 4Prasad P, Tiwari AK, Kumar KM, et al. Association of TGFbe-tal, TNFalpha, CCR2 and CCR5 gene polymorphisms in type -2 diabetes and renal insufficiency among Asian Indians. BMC Med Genet,2007,8 : 20.
  • 5Tu Y, Wu T, Dai A, et al. Cell division autoantigen 1 enhances signaling and the profibrotic effects of transforming growth factor - beta in diabetic nephropathy. Kidney Int, 2011,7 ( 2 ) ) : 199 - 209.
  • 6Ziyadeh FN. Different roles for TGF - beta and VEGF in the pathogenesis of the cardinal features of diabetic nephropathy. Dia- betes Res Clin Pract. 2008 Nov 13 ;82 Suppl 1 :$38 -gl.
  • 7Nguyen TQ, Roestenberg P, van Nieuwenhoven FA, et al. CTGF inhibits BMP - 7 signaling in diabetic nephropathy. J Am Soc Nephrol,2008,19 ( 11 ) :2098 - 2107.
  • 8Mou S, Wang Q, Shi B, et al. Hepatocyte growth factor suppres- ses transforming growth factor - beta - 1 and type III collagen in human primary renal fibroblasts. Kaohsiung J Med Sei, 2009,25 (11) :577 -587.
  • 9Yeo ES, Hwang JY, Park JE, et al. Tumor necrosis factor (TNF -alpha) and C -reactive protein (CRP) are positively associat- ed with the risk of chronic kidney disease in patients with type 2 diabetes. Yonsei Med J,2010,51 (4) :519 - 525.
  • 10Navarro - Gonzalez JF, Jarque A, Muros M, et al. Tumor necro- sis factor - alpha as a therapeutic target for diabetic nephropathy. Cytokine Growth Factor Rev ,2009 : 165 - 173.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部